Purple Biotech Ltd ADR (PPBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 0 | 1,000 | 1,000 | 100 | 0 |
| Gross Profit | N/A | 1,000 | 1,000 | 100 | N/A |
| Operating Expenses | 13,239 | 8,156 | 8,826 | 12,066 | 7,183 |
| Operating Income | -13,239 | -7,156 | -7,826 | -11,966 | -7,183 |
| Interest Expense | 61 | 181 | 576 | 26 | 61 |
| Other Income | -15,401 | 1,660 | 2,833 | -921 | -4,881 |
| Pre-tax Income | -28,701 | -5,677 | -5,569 | -12,913 | -12,125 |
| Income Tax | N/A | 216 | N/A | N/A | N/A |
| Net Income Continuous | -28,701 | -5,893 | -5,569 | -12,913 | -12,125 |
| Net Income Discontinuous | 627 | N/A | N/A | N/A | N/A |
| Minority Interests | -75 | -43 | -369 | -736 | N/A |
| Net Income | $-27,999 | $-5,850 | $-5,200 | $-12,177 | $-12,125 |
| EPS Basic Total Ops | -490.00 | -600.00 | -780.00 | -2,740.00 | -4,214.00 |
| EPS Basic Continuous Ops | -499.15 | -608.47 | -784.09 | -2,730.97 | -4,213.18 |
| EPS Basic Discontinuous Ops | 10.90 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -490.00 | -600.00 | -780.00 | -2,740.00 | -4,214.00 |
| EPS Diluted Continuous Ops | -499.15 | -608.47 | -784.09 | -2,730.97 | -4,213.18 |
| EPS Diluted Discontinuous Ops | 10.90 | N/A | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -216.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-13,004 | $-6,978 | $-7,819 | $-11,962 | $-7,181 |